Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian F Pollack

Showing results (181-190 of 308) with videos related to

Pageof 31
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II studyRegina I Jakacki, Peter C Burger, Tianni Zhou, et al.
Journal of Neurosurgery. Pediatrics|September 15, 2018
Variation in the management of isolated craniosynostosis: a survey of the Synostosis Research GroupJohn R W Kestle, Amy Lee, Richard C E Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium studyKurt A Jaeckle, Kenneth R Hess, W K Alfred Yung, et al.
JCI Insight|April 6, 2018
Peptide vaccine immunotherapy biomarkers and response patterns in pediatric gliomasSören Müller, Sameer Agnihotri, Karsen E Shoger, et al.
Pediatric Blood & Cancer|April 30, 2013
Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working groupKatherine E Warren, Tina Y Poussaint, Gilbert Vezina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology GroupJoann L Ater, Tianni Zhou, Emiko Holmes, et al.
Neuro-Oncology|March 24, 2016
Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 studyRegina I Jakacki, Kenneth J Cohen, Allen Buxton, et al.
Expert Review of Clinical Immunology|October 15, 2024
Assessment of anti-CD69 antibody therapy alone or in combination with anti-PD-1 in murine GBMMichal Nisnboym, Chaim T Sneiderman, Ambika P Jaswal, et al.
Molecular Cancer Research : MCR|April 3, 2020
Targeting NAD<sup>+</sup> Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma ResistanceEsther P Jane, Daniel R Premkumar, Swetha Thambireddy, et al.
Pediatric Blood & Cancer|September 20, 2008
Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology GroupJonathan L Finlay, Girish Dhall, James M Boyett, et al.
Pageof 31

Showing results (181-190 of 308) with videos related to

Sort By:
Pageof 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II studyRegina I Jakacki, Peter C Burger, Tianni Zhou, et al.
Journal of Neurosurgery. Pediatrics|September 15, 2018
Variation in the management of isolated craniosynostosis: a survey of the Synostosis Research GroupJohn R W Kestle, Amy Lee, Richard C E Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium studyKurt A Jaeckle, Kenneth R Hess, W K Alfred Yung, et al.
JCI Insight|April 6, 2018
Peptide vaccine immunotherapy biomarkers and response patterns in pediatric gliomasSören Müller, Sameer Agnihotri, Karsen E Shoger, et al.
Pediatric Blood & Cancer|April 30, 2013
Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working groupKatherine E Warren, Tina Y Poussaint, Gilbert Vezina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology GroupJoann L Ater, Tianni Zhou, Emiko Holmes, et al.
Neuro-Oncology|March 24, 2016
Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 studyRegina I Jakacki, Kenneth J Cohen, Allen Buxton, et al.
Expert Review of Clinical Immunology|October 15, 2024
Assessment of anti-CD69 antibody therapy alone or in combination with anti-PD-1 in murine GBMMichal Nisnboym, Chaim T Sneiderman, Ambika P Jaswal, et al.
Molecular Cancer Research : MCR|April 3, 2020
Targeting NAD<sup>+</sup> Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma ResistanceEsther P Jane, Daniel R Premkumar, Swetha Thambireddy, et al.
Pediatric Blood & Cancer|September 20, 2008
Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology GroupJonathan L Finlay, Girish Dhall, James M Boyett, et al.
Pageof 31